BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22704450)

  • 1. Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834.
    Ravi P; Sammon J; Meskawi M; Sun M; Karakiewicz PI; Trinh QD
    J Urol; 2012 Aug; 188(2):677-8. PubMed ID: 22704450
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
    Singh I; Gautam L
    J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
    Eggener S
    Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications after prostate biopsy: data from SEER-Medicare.
    Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
    J Urol; 2011 Nov; 186(5):1830-4. PubMed ID: 21944136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.
    Horan AH
    J Urol; 2013 Sep; 190(3):1139. PubMed ID: 23583228
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.
    Chamberland RR
    J Clin Microbiol; 2016 Oct; 54(10):2431-5. PubMed ID: 27147719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program J. J. Tosoian, S. Loeb, A. Kettermann, P. Landis, D. J. Elliot, J. I. Epstein, A. W. Partin, H. B. Carter and L. J. Sokoll J Urol 2010; 183: 534-538.
    Papatsoris A; Bourdoumis A; Chrisofos M
    J Urol; 2010 Jul; 184(1):396-7. PubMed ID: 20488485
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
    Ng CF; Chan SY
    J Urol; 2008 Oct; 180(4):1570-1; author reply 1571. PubMed ID: 18718610
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. A. S. Duffield, T. K. Lee, H. Miyamoto, H. B. Carter and J. I. Epstein. J Urol 2009; 182: 2274-2278.
    Lawrentschuk N; Fleshner NE
    J Urol; 2010 May; 183(5):2099. PubMed ID: 20303514
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance K. Fujika, P. Landis, B. K. McNeil and C. P. Pavlovich J Urol 2009; 182: 2664-2669.
    Atan A; Tuncel A
    J Urol; 2010 Jun; 183(6):2471-2. PubMed ID: 20416896
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Factors predicting prostatic biopsy Gleason sum under grading: D. A. Stackhouse, L. Sun, F. R. Schroeck, J. Jayachandran, A. A. Caire, C. O. Acholo, C. N. Robertson, D. M. Albala, T. J. Polascik, C. F. Donatucci, K. E. Maloney and J. W. Moul J Urol 2009; 182: 118-124.
    Labanaris AP; Kühn R; Zugor V
    J Urol; 2010 Jan; 183(1):396-7; author reply 397-8. PubMed ID: 19945124
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163-1169.
    Shah N; Ioffe V
    J Urol; 2015 Dec; 194(6):1825-6. PubMed ID: 26354886
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.
    Eskicorapci SY; Tuncay L
    J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply by authors.
    J Urol; 2013 Oct; 190(4):1440. PubMed ID: 23886879
    [No Abstract]   [Full Text] [Related]  

  • 15. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores.
    Pepe P; Aragona F
    Urology; 2013 Jun; 81(6):1142-6. PubMed ID: 23726443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system. B. J. Trock, C. C. Guo, M. L. Gonzalgo, A. Magheli, S. Loeb and J. I. Epstein. J Urol 2009; 182: 1364-1370.
    Ikenberg K; Zimmermann AK; Kristiansen G
    J Urol; 2010 May; 183(5):2100; author reply 2100-1. PubMed ID: 20359717
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.
    Atmaca AF; Balbay MD
    J Urol; 2009 May; 181(5):2387-8. PubMed ID: 19303084
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Delay of surgery in men with low risk prostate cancer: D. O'Brien, S. Loeb, G. F. Carvalhal, B. B. McGuire, D. Kan, M. D. Hofer, J. T. Casey, B. T. Helfand and W. J. Catalona J Urol 2011; 185: 2143-2147.
    Ghosh B; Muruganandham K; Dorairajan LN; Kumar S
    J Urol; 2012 Jul; 188(1):331; author reply 331-2. PubMed ID: 22608754
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Delay of surgery in men with low risk prostate cancer: D. O'Brien, S. Loeb, G. F. Carvalhal, B. B. McGuire, D. Kan, M. D. Hofer, J. T. Casey, B. T. Helf and W. J. Catalona. J Urol 2011; 185: 2143-2147.
    Klotz L
    J Urol; 2011 Dec; 186(6):2505; author reply 2506. PubMed ID: 22033446
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.
    Pinkhasov GI; Lin YK; Palmerola R; Smith P; Mahon F; Kaag MG; Dagen JE; Harpster LE; Reese CT; Raman JD
    BJU Int; 2012 Aug; 110(3):369-74. PubMed ID: 22313996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.